Annual report pursuant to Section 13 and 15(d)

STOCK COMPENSATION PLANS (Details)

v3.8.0.1
STOCK COMPENSATION PLANS (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
STOCK COMPENSATION PLANS [Abstract]      
Total stock-based compensation expense $ 219.0 $ 258.0 $ 236.0
Total income tax benefit recognized in consolidated statements of income for share-based compensation arrangements 44.0 $ 71.0 $ 65.0
Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted $ 286.0    
Weighted-average period over which the total unrecognized compensation cost is expected to be recognized (in years) 3 years    
Weighted-average assumptions used in the Black Scholes Merton option pricing model      
Fair value of options at grant date (in dollars per share) $ 3.98 $ 4.17 $ 4.38
Dividend yield (as a percent) 3.60% 3.20% 3.10%
Expected volatility (as a percent) 15.50% 16.00% 16.00%
Risk-free interest rate (as a percent) 2.20% 1.50% 1.80%
Expected term of the option (in years) 6 years 6 years 6 years
Share-based compensation disclosure      
Granted (in shares) 9,000,000    
Exercised (in shares) (53,000,000) (50,000,000) (44,000,000)
Forfeited/expired (in shares) (3,000,000)    
Outstanding on December 31 173,000,000 220,000,000  
Expected to vest 171,000,000    
Granted, Weighted-Average Exercise Price (in dollars per share) $ 40.89    
Exercised, Weighted-Average Exercise Price (in dollars per share) 30.28    
Forfeited/expired, Weighted-Average Exercise Price (in dollars per share) 38.34    
Outstanding on December 31, Weighted-Average Exercise Price (in dollars per share) 35.02 $ 33.70  
Expected to vest, Weighted-Average Exercise Price (in dollars per share) $ 34.96    
Expected to Vest, Weighted Average Remaining Contractual Life (in years) 4 years 8 months 53 days    
Outstanding on December 31, 2017, Weighted-Average Remaining Contractual Life (in years) 4 years 8 months 64 days    
Outstanding on December 31, 2017, Aggregate Intrinsic Value (in dollars) $ 1,879.0    
Expected to vest, Aggregate Intrinsic Value (in dollars) $ 1,869.0    
Exercisable on December 31, 2017 142,000,000    
Exercisable on December 31, 2017 weighted average exercise price (in dollars per share) $ 33.89    
Exercisable on December 31, 2017, Weighted-Average Remaining Contractual Life (in years) 4 years 2 months 36 days    
Exercisable on December 31, 2017, Aggregate Intrinsic Value (in dollars) $ 1,700.0    
Total intrinsic value of options exercised $ 744.0 $ 787.0 $ 594.0
Number of Shares Available for Grant (in shares) 2,700,000    
Vesting period of stock-based awards (in years) 4 years    
Summary disclosures      
Outstanding performance share units at the Threshold Award Level (in shares) 2,200,000    
Outstanding performance share units at the Maximum Award Level (in shares) 15,400,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other-than-Options Paid in Cash Equivalent in Period Value $ 0.4 $ 1.9  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 years    
CCE's North American business      
Share-based compensation disclosure      
Outstanding on December 31 300,000    
Outstanding on December 31, Weighted-Average Exercise Price (in dollars per share) $ 12.86    
Expiration period of stock-based awards (in years) 10 years    
Vesting period of stock-based awards (in years) 3 years    
Restricted Stock Units (RSUs) [Member]      
Share-based compensation disclosure      
Vesting period of stock-based awards (in years) 5 years    
Summary disclosures      
Canceled/forfeited (in shares) (430,000)    
Outstanding on January 1, 2017 $ 0.00    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversions in Period 7,181,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversions, Weighted Average Grant Date Fair Value $ 32.33    
Canceled/forfeited, Weighted-Average Grant-Date Fair Value (in dollars per share) 32.30    
Outstanding on December 31 $ 32.35 $ 0.00  
Restricted shares units vested and released (in shares) (3,000)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 32.35    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 6,748,000 0  
2014 Equity Plan      
Share-based compensation disclosure      
Common stock was approved to be issued or transferred through the grant of stock options (in shares) 500,000,000    
Number of Shares Available for Grant (in shares) 413,600,000    
Stock options granted from 1999 through July 2003      
Stock-based compensation awards      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 15 years    
Stock options granted in December 2003 and thereafter      
Stock-based compensation awards      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 10 years    
Performance share units [Member]      
Summary disclosures      
Granted 4,133,000    
Paid in cash equivalent (in shares) (11,052) (52,545)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other Than Options, Paid in Cash Equivalent in Period, Weighted-average Grant Date Fair Value $ 34.15    
Canceled/forfeited (in shares) (832,000)    
Outstanding on December 8,212,000 9,773,000  
Outstanding on January 1, 2017 $ 35.77    
Grants in Period, Weighted Average Grant Date Fair Value $ 34.75 $ 39.70 $ 37.99
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversions in Period (4,851,000)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Conversions, Weighted Average Grant Date Fair Value $ 32.35    
Canceled/forfeited, Weighted-Average Grant-Date Fair Value (in dollars per share) 37.20    
Outstanding on December 31 $ 37.14 35.77  
Performance share units [Member] | Performance Period 2015 to 2017 [Member]      
Summary disclosures      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 2,088,000    
Performance share units [Member] | Performance Period 2016 to 2018 [Member]      
Summary disclosures      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 2,985,000    
Performance share units [Member] | Performance Period 2017 to 2019 [Member]      
Summary disclosures      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 3,139,000    
Time-Based Restricted Stock Unit Awards      
Summary disclosures      
Granted 2,994,000    
Canceled/forfeited (in shares) (50,000)    
Outstanding on January 1, 2017 $ 37.54    
Grants in Period, Weighted Average Grant Date Fair Value 41.62    
Canceled/forfeited, Weighted-Average Grant-Date Fair Value (in dollars per share) 38.35    
Outstanding on December 31 $ 40.99 $ 37.54  
Restricted shares units vested and released (in shares) (179,000)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 37.36    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 3,534,660 770,000  
Restricted stock award plan [Member]      
Share-based compensation disclosure      
Number of Shares Available for Grant (in shares) 200,000    
Summary disclosures      
Restricted shares units vested and released (in shares) (3,037) (7,101) (130,017)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested $ 1.0 $ 1.0 $ 5.0